Published on August 21, 2012 at 3:12 AM
Bonovo® Orthopedics, Inc. announced today that it has launched the first
PEEK (PEEK-OPTIMA® polymer from INVIBIO®) lateral
interbody fusion cage, Cross-Fuse® in China. Minimally Invasive Lateral
Interbody Fusion (MILIF) had been gaining increasing popularity in the
U.S. and Europe due to its less invasive nature and proven safety and
effectiveness.
According to Chip Bao, Ph.D., Bonovo's Chief Executive Officer, "We feel
extremely privileged to be the first to introduce this new technology
into China so Chinese patients can benefit from this minimally invasive
surgical treatment with proven clinical results. The speed of approval
through the SFDA of this important therapy is a testament to the
expertise of the Bonovo clinical and regulatory team."
Professor Xifeng Zhang, M.D., Director of Minimally Invasive Surgery
(MIS) of the Orthopedic Department at 301 Hospital in Beijing,
successfully performed the first Cross-Fuse® surgery at 301 Hospital in
China with Dr. John Regan, a world renowned spine surgeon specializing
in MIS. Professor Zhang stated, "Many Chinese surgeons have been waiting
for this new technique for a long time so they can apply this minimally
invasive surgery to their patients. Like the rest of the world, MIS has
become a strong trend in China. In general, Chinese patients tend to
favour conservative care or less invasive surgeries. With the SFDA
approval of Cross-Fuse®, I am glad that Chinese surgeons finally have
another minimally invasive surgical option to treat their patients with
lumbar degenerative disc disease."
Source: Bonovo Orthopedics, Inc.